Package Insert: Information for the User
Diclokern 11.6 mg/g gel
Diclofenac diethylamine
Read this entire package insert carefully before starting to use this medication because it contains important information for you.
Follow exactly the medication administration instructions contained in this package insert or those indicated by your doctor or pharmacist.
The active ingredient diclofenac diethylamine, belongs to the group of non-steroidal anti-inflammatory drugs and acts as a local analgesic and anti-inflammatory.
Diclokern is indicated in adults and adolescents over 14 years old for local relief of mild and occasional pain and inflammation caused by:
-small bruises, blows, strains,
-stiff neck or other contractures,
-backaches,
-mild sprains resulting from a twist.
Consult a doctor if it worsens or does not improve after 7 days.
If you think you may be allergic, consult your doctor.
Warnings and precautions
Consult your doctor or pharmacist before starting to use Diclokern.
Children and adolescents
This medication is not recommended for use in children and adolescents under 14 years old, due to insufficient data on safety and efficacy.
Use of Diclokern with other medications
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, or intend to become pregnant, consult your doctor or pharmacist before using this medication.
Pregnancy
Do not use Diclokern if you are in the last 3 months of pregnancy. Do not use Diclokern during the first 6 months of pregnancy, unless it is strictly necessary and recommended by your doctor. If you need treatment during this period, you should take the minimum dose possible for the shortest time possible.
The oral formulations (e.g., tablets) of diclofenac may cause adverse reactions to the fetus. It is unknown whether this same risk applies to Diclokern when used on the skin.
Breastfeeding
Consult your doctor or pharmacist before using any medication.
Do not use Diclokern during breastfeeding, except as directed by your doctor.
Do not apply directly to the breast area.
Driving and operating machinery
No effects on the ability to drive vehicles and operate machinery have been described when using Diclokern externally on the skin.
Diclokern contains propylene glycol (E-1520)
This medication contains 50 mg of propylene glycol in each gram of gel.
Follow exactly the medication administration instructions contained in this leaflet or those indicated by your doctor. In case of doubt, ask your doctor or pharmacist.
This medication is for application on the skin (cutaneous use).
Recommended dose is:
Adults and adolescents over 14 years:Apply 3 or 4 times a day a small amount of gel on the inflamed or painful area.
The amount of gel will vary depending on the size of the affected area (usually, it will be sufficient to apply an amount similar to the size of a cherry or a walnut).
Use in childrenand adolescents
This medication is not recommended for use in children and adolescents under 14 years, due to insufficient available data on safety and efficacy.
Method of use:
If the pain or swelling worsen or persist after 7 days of treatment, consult your doctor.
If you use more Diclokern than you should
If you accidentally ingest Diclokern or if you have used it on a large area of the skin and for a long period of time, similar adverse reactions to those produced by diclofenac when taken orally (e.g. tablets) may occur.
The main symptoms of overdose are: gastrointestinal or renal disorders and difficulty breathing, nausea, vomiting, abdominal pain, and decreased level of consciousness may occur.
If you have applied too much of the medication, it is recommended to remove it by washing the affected area with plenty of water, or by removing a part.
In case of accidental ingestion, go immediately to a medical center or call the Toxicological Information Service, phone: 91 562 04 20 indicating the medication and the amount ingested.
If you forgot to use Diclokern
If you forgot to apply this medication when due, apply the gel as soon as possible and continue with the normal treatment.
Do not apply a double dose to compensate for the missed doses.
If you interrupt the treatment with Diclokern
If you have any other doubt about the use of this product, ask your doctor or pharmacist.
Like all medications, this medication may produce adverse effects, although not all people will experience them.
Some rare and very rare adverse effects can be severe:
If you experience any of the following signs of allergy, stop using Diclokern and consult your doctor or pharmacist immediately:
Mild Adverse Effects:
Other adverse effects may occur, but these are usually mild and of short duration. If you notice any of them, consult your doctor or pharmacist as soon as possible.
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this prospectus. You can also report them directly through theSpanish System for Pharmacovigilance of Medicines for Human Use https://www.notificaram.es.By reporting adverse effects, you can contribute to providing more information about the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not store at a temperature above30°C.
Do not use this medication after the expiration date that appears on the packaging after “CAD”. The expiration date is the last day of the month indicated.
Once opened, discard the tube with the remaining gel after 12 months.
Medicines should not be disposed of through drains or in the trash. Deposit the packaging and unused medicines at the SIGRE collection pointat the pharmacy.If in doubt, ask your pharmacist how to dispose of the packaging and unused medicines. By doing so, you will help protect the environment.
Composition of Diclokern
Appearance of the product and contents of the packaging
Diclokern is a viscous and white gel. It is packaged in an aluminum tube with a screw cap.
The medicine is presented in a tube with 60 and 100 grams of gel.
Only some sizes of packaging may be commercially available.
Holder of the marketing authorization and responsible for manufacturing
Kern Pharma, S.L.
Venus, 72 - Pol. Ind.Colón II
08228 Terrassa - Barcelona
Spain
Last review date of this leaflet: September 2019
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/.
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.